David Emerson Jorden, CEO/CFO, Director at Nuo Therapeutics, holds 2.07M shares in Nuo Therapeutics (Ticker: AURX), holds ― shares in PLx Pharma (Ticker: PLXPQ), holds 293.46K shares in Acer Therapeutics (Ticker: ACER).
What is the percentage of profitable transactions made by David Emerson Jorden?
The percentage of profitable transactions made by David Emerson Jorden is 50%.
What is the average return per transaction made by David Emerson Jorden?
The average return per transaction made by David Emerson Jorden is -0.90%.
What stocks does David Emerson Jorden hold?
David Emerson Jorden holds: AURX, PLXPQ, CNOB, ACER stocks.
What was David Emerson Jorden’s latest transaction?
David Emerson Jorden latest transaction was an Uninformative Buy of $9.47K.
What was David Emerson Jorden's most profitable transaction?
David Emerson Jorden’s most profitable transaction was an Informative Sell of AURX stock on November 14, 2022. The return on the trade was 68.40%.
What is David Emerson Jorden's role in Nuo Therapeutics?
David Emerson Jorden's role in Nuo Therapeutics is CEO/CFO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.